Related Experiment Video
Updated: Aug 15, 2026

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
Published on: August 30, 2011
[Effects of captopril on the myocardial performances and hemodynamics after cardiac arrest]
Unlabelled:
The effects of cardioplegia and reperfusional blood containing 4.6 mumol/L captopril (CPL) on the myocardial performances and hemodynamics of canine heart under hypothermic extracorporeal circulation were studied. Twenty four mongrel dogs were divided randomly into 3 groups.
Control Group:
Only modified St. Thomas cardioplegia was used. CPL group: St. Thomas cardioplegia containing CPL 4.6 mumol/L was used and the same concentration of captopril in the circulatory blood was established before releasing the cross clamp. CPL + phenylephrine group: The concentration was the same as the CPL group, with an additional dose of phenylephrine (2 micrograms/kg) into the oxygenator and abdominal coarctation. The results revealed that the coronary blood flow and left ventricular contractility and relaxation indices of CPL group were significantly improved than those of the control group, and increasing the systemic and pulmonary vascular resistence had no effect on the cardiac function protected by captopril. It is suggested that captopril could ameliorate the recovery of myocardial performences by inhibitting myocardial and systemic renin-angiotensin system and scavenging free radicals.
More Related Videos
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy